{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:56Z","timestamp":1786991636694,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jchf.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:33:04Z","timestamp":1620837184000},"page":"430-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart\u00a0Failure"],"prefix":"10.1016","volume":"9","author":[{"given":"JoAnn","family":"Lindenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanda","family":"Grazette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2021.01.012_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics\u20142020 Update","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2021.01.012_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2021.01.012_bib3","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with\u00a0heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9149(92)90734-G","article-title":"Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD)","volume":"70","author":"Johnstone","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1067\/mhl.2001.114140","article-title":"Quality of life in patients with heart failure: do gender differences exist?","volume":"30","author":"Riedinger","year":"2001","journal-title":"Heart Lung"},{"key":"10.1016\/j.jchf.2021.01.012_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jacc.2003.10.064","article-title":"The influence of age, gender, and race on the prevalence of depression in heart failure patients","volume":"43","author":"Gottlieb","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib8","first-page":"1417","article-title":"Where are all the women with heart failure?","volume":"30","author":"Lindenfeld","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.09.081","article-title":"Differential impact of heart failure with reduced ejection fraction in men and women","volume":"73","author":"Dewan","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib11","doi-asserted-by":"crossref","first-page":"i1855","DOI":"10.1136\/bmj.i1855","article-title":"Effect of age and sex on efficacy and tolerability of \u03b2 blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2021.01.012_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"34","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacc.2018.10.041","article-title":"Women with heart failure: unheard, untreated, and unstudied","volume":"73","author":"Walsh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib15","first-page":"487","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2021.01.012_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ejhf.299","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy","volume":"17","author":"Zile","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2021.01.012_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the BAROSTIM NEO trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.jchf.2021.01.012_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehi446","article-title":"How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts","volume":"27","author":"McAlister","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2021.01.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: BeAT-HF study results","volume":"76","author":"Zile","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib20","series-title":"Expedited access for premarket approval and de novo medical devices intended for unmet medical need for life threatening or irreversibly debilitating diseases or conditions; guidance for industry and Food and Drug Administration staff; availability","year":"2015"},{"key":"10.1016\/j.jchf.2021.01.012_bib21","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib22","first-page":"2972","article-title":"Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy","volume":"7","author":"Wilkoff","year":"2020","journal-title":"ESC Heart\u00a0Failure"},{"key":"10.1016\/j.jchf.2021.01.012_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176248","article-title":"The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis","volume":"12","author":"Yin","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchf.2021.01.012_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide\u2013guided therapy on hospitalization or cardiovascular mortality in high-risk patients with Heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2021.01.012_bib25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCHEARTFAILURE.112.000174","article-title":"Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure","volume":"6","author":"Brenyo","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2021.01.012_bib26","first-page":"813","article-title":"Cardiac resynchronization therapy is more effective in women than in men. The MADIT-CRT trial","volume":"57","author":"Arshad","year":"2011","journal-title":"J\u00a0Am Coll Card"},{"key":"10.1016\/j.jchf.2021.01.012_bib27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jce.12701","article-title":"Sex differences in device therapies for ventricular arrhythmias or death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial","volume":"26","author":"Tompkins","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2021.01.012_bib28","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamainternmed.2014.2717","article-title":"Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data","volume":"174","author":"Zusterzeel","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-156-3-201202070-00007","article-title":"Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database","volume":"156","author":"MacFadden","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2021.01.012_bib30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.amjcard.2013.06.031","article-title":"Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device","volume":"112","author":"Sohail","year":"2013","journal-title":"Am J Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177921000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177921000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:57:54Z","timestamp":1761973074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177921000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213177921000603"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2021.01.012","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}